Analysis of the treatment of RT2 recessions with a xenogeneic collagen matrix vs. connective tissue graft combined with a coronally advanced flap. A double-blinded randomized clinical trial
dc.contributor.author | Ruiz de Gopegui Palacios, Elena | |
dc.contributor.author | Vilor Fernández, Miren | |
dc.contributor.author | García de la Fuente, Ana María ![]() | |
dc.contributor.author | Marichalar Mendia, Xabier | |
dc.contributor.author | Aguirre Zorzano, Luis Antonio | |
dc.date.accessioned | 2024-04-18T17:59:33Z | |
dc.date.available | 2024-04-18T17:59:33Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Clinical Oral Investigations 28 : (2024) // Article ID 218 | es_ES |
dc.identifier.issn | 1436-3771 | |
dc.identifier.uri | http://hdl.handle.net/10810/66788 | |
dc.description.abstract | Objectives To compare the clinical efficacy in terms of mean root coverage in RT2 recession treated with a coronally advanced flap combined with a xenogeneic collagen matrix versus a connective tissue graft. Materials and methods A total of 20 patients were randomized to receive one of two treatments: coronally advanced flap + xenogeneic collagen matrix (test group) and coronally advanced flap + connective tissue graft (control group). Patient- related outcomes measures and professional aesthetic assessment by root esthetic score were performed. A descriptive and analytical statistical analysis of the variables was performed. Results At 12 months, the mean root coverage was 56.48% in the test group and 69.72% in the control group (p = 0.048), with a 35% and 40% complete root coverage in the xenogeneic collagen matrix and connective tissue graft, respectively. Test group presented less pain (3.65 vs. 5.2 VAS units) (p = 0.015) and less surgical time (45 vs. 49.15 min) (p = 0.004) than control group. Conclusion The use of xenogeneic collagen matrix in RT2 recessions was effective for recession reduction to those obtained using autologous grafts; with the advantage that the duration of surgery and patient morbidity decreased. Therefore, xenoge- neic collagen matrix in RT2 recessions could be an alternative to autologous grafts. Clinical relevance The use of xenogeneic collagen matrix decreases the surgery time and patient morbidity but connective tissue graft results in significantly better mean root coverage and complete root coverage. Xenogeneic collagen matrix can be used in the treatment of RT2 gingival recessions. Study registration NCT 03344315 | es_ES |
dc.description.sponsorship | Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Study materials were kindly provided by Geistlich Pharma, AG (Wolhusen/ Switzerland). Open Access funding provided by the University of Basque Country (UPV/EHU), Leioa, Biscay, Spain. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Springer Nature | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | collagen matrix | es_ES |
dc.subject | gingival recession | es_ES |
dc.subject | connective tissue | es_ES |
dc.subject | plastic surgery procedures | es_ES |
dc.subject | clinical trial | es_ES |
dc.title | Analysis of the treatment of RT2 recessions with a xenogeneic collagen matrix vs. connective tissue graft combined with a coronally advanced flap. A double-blinded randomized clinical trial | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | © The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://link.springer.com/article/10.1007/s00784-024-05602-9 | es_ES |
dc.identifier.doi | 10.1007/s00784-024-05602-9 | |
dc.departamentoes | Estomatologia I | es_ES |
dc.departamentoes | Enfermería | es_ES |
dc.departamentoeu | Erizaintza | es_ES |
dc.departamentoeu | Estomatologia | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.